CUSIP 12674W109COMCABAQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
95 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Bain Capital Life Sciences Investors, LLC | 9.68M | $21.19M | 0 | Held |
| 2 | Jennison Associates LLC | 8.91M | $19.50M | +408.2K | Added |
| 3 | Adage Capital Partners Gp, L.L.C. | 8.83M | $19.34M | 0 | Held |
| 4 | Vanguard Group Inc | 4.42M | $9.68M |
| +228.7K |
| Added |
| 5 | Cormorant Asset Management, LP | 4.40M | $9.64M | −600.0K | Reduced |
| 6 | Millennium Management LLC | 2.74M | $5.99M | +2.05M | Added |
| 7 | Blackrock, Inc. | 2.33M | $5.10M | +707.6K | Added |
| 8 | Superstring Capital Management LP | 2.25M | $4.94M | +709.0K | Added |
| 9 | Two Sigma Investments, LP | 1.84M | $4.03M | +1.37M | Added |
| 10 | Renaissance Technologies LLC | 1.52M | $3.33M | +183.2K | Added |
See every fund holding Cabaletta Bio Inc, with full quarter-over-quarter share changes.
Unlock all holders